The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat

Journal of Neuroscience

Volumn 16, Issue 10, 1996, Pages 3507-3510

  Wilson, Julie M ^a   Kish, Stephen J ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

cocaine; dihydrotetrabenazine; quantitative autoradiography; self administration; unlimited access; vesicular monoamine transporter

Indexed keywords

COCAINE; DIHYDROTETRABENAZINE; DOPAMINE; MONOAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN CORTEX; BRAIN STEM; CONTROLLED STUDY; DIENCEPHALON; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG SELF ADMINISTRATION; MALE; MESENCEPHALON; MONOAMINE RELEASE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE;

EID: 0030002053     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-10-03507.1996     Document Type: Article

References (27)

1. Alburges ME, Narang N, Wamsley JK (1993) Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14:314-323.
2. Bennett BA, Hyde CE, Pecora JR, Clodfelter JE (1993a) Long-term cocaine administration is not neurotoxic to cultured fetal mesencephalic dopamine neurons. Neurosci Lett 153:210-214.
3. Bennett BA, Hyde CE, Pecora JR, Clodfelter JE (1993b) Differing neurotoxic potencies of methamphetamme, mazindol, and cocaine in mesencephalic cultures. J Neurochem 60:1444-1452.
4. Cass WA, Gerhardt GA (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 176:259-263.
5. 125I]iodoketanserin. Neuroscience 33:341-349.
6. Farfel GM, Kleven MS, Woolverton WL, Seiden LS, Perry BD (1992) Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in Rhesus monkeys. Brain Res 578:235-243.
7. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 34:423-431.
8. Greengard P, Valtorta F, Czernik AJ, Benfenati F (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259:780-785.
9. Hitri A, Suddath RL, Wyatt RJ (1989) Effect of cocaine withdrawal on dopamine uptake sites in the rat frontal cortex. Biol Psychiatry 25:48A.
10. Innes RB (1994) Single-photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease. Eur J Nucl Med 21:1-5.
11. Kelly RB (1993) Storage and release of neurotransmitters. Neuron [Suppl] 10:43-53.
12. 18F]GBR 13119 binding to the dopamine uptake site. Eur J Pharmacol 216:109-112.
13. 3H]dihydrotetrabenazine, a new marker for the visualisation of dopaminergic denervation in the rat striatum. Neurosci Lett 114:45-50.
14. Naudon L, Leroux-Nicollet I, Costentin J (1994) Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra. Neurosci Lett 173:1-4.
15. Parsons LH, Smith AD, Justice Jr JB (1991) Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 9:60-65.
16. Pettit HO, Justice Jr JB (1991) Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res 539:94-102.
17. Rostène W, Boja JW, Scherman D, Carrol FI, Kuhar MJ (1992) Dopamine transport: pharmacological distinction between the synaptic membrane and the vesicular transporter in rat striatum. Eur J Pharmacol 218:175-177.
18. Ryan LJ, Martone ME, Linder JC, Groves PM (1988) Cocaine, in contrast to D-amphetamine, does not cause axonal terminal degeneration in neostriatum and agranular frontal cortex of Long-Evans rats. Life Sci 43:1403-1409.
19. Scherman D (1986) Dihydrotetrabenazine binding and monoamine uptake in mouse brain regions. J Neurochem 47:331-339.
20. 3H]dihydrotetrabenazine binding sites in mouse brain and its relationship to the distribution of monoamines and their metabolites. Brain Res 370:176-181.
21. 3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain. J Neurochem 50:1131-1136.
22. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn Schmiedebergs Arch Pharmacol 329:227-235.
23. Seiden LS, Kleven MS (1988) Lack of toxic effects of cocaine on dopamine or serotonin neurons in the rat brain. In: Mechanisms of cocaine abuse and toxicity, pp 276-289. Washington, DC: NIDA Research Monograph Series, U.S. Department Health and Human Services.
24. 3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur J Pharmacol 203:141-144.
25. Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K (1995) The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Eur J Pharmacol 294:577-583.
26. Weiner HL, Hashim A, Lajtha A, Sershen H (1989) Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier. Eur J Pharmacol 163:191-194.
27. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14: 2966-2979.